-
-
BranchLab Launches Scientific Advisory Board Featuring Two of the Country’s Leading AI Academic Researchers
BOULDER, Colo., Sept. 24, 2025 /PRNewswire/ — BranchLab today announced the formation of its Scientific Advisory Board, bringing two of the country’s leading AI academic researchers into its work at the intersection…
-
Investing in BranchLab: AI-Native Solutions for Healthcare Marketers
The U.S. healthcare digital audience market, despite being fueled by tens of billions in pharmaceutical marketing spend, remains defined by three structural challenges. First, it is anchored to commoditized datasets,…
-
Next Ventures Announces Strategic Investment in BranchLab to Accelerate AI Innovation in Privacy-Proactive, Precision Healthcare
AUSTIN, Texas and BOULDER, Colo., Sept. 8, 2025 /PRNewswire/ — Next Ventures, a venture capital firm dedicated to advancing whole-person health, today announced a strategic investment in BranchLab, a provider of AI-native solutions for healthcare marketing….
-
Exclusive: Lance Armstrong’s VC Firm Invests In AI-Powered Health Care Ad Tech Startup BranchLab
After a seed round last June, Josh Walsh wasn’t looking to raise more funding this year for BranchLab, an AI startup for health care marketers that he co-founded in early 2024….
-
Pharma marketers weigh economy and chance of TV ad ban during upfronts season
As economic and regulatory uncertainty loom over the 2025 TV upfronts, pharma marketers are rethinking how they show up across media. In Sam Bradley’s latest piece for Digiday, our EVP…
-
After FTC Commissioners Fired, Marketers Speculate on Future of Industry Regulation
BranchLab CEO, Josh Walsh, weighs in on the role state regulations will play for marketers, especially pharma advertisers, in the vacuum of federal regulation.
-
20 Ad Tech Executives Predict 2025 Trends
BranchLab’s Michael Parkes predicts: “State privacy regulations, such as Washington’s My Health My Data Act, will profoundly reshape pharmaceutical advertising by imposing strict limitations on the use of health data….
-
Is Targeted Pharma Advertising Over? Not Quite
BranchLab’s Michael Parkes provides an overview of the emerging state regulations impacting the media strategies of pharmaceutical and healthcare brands, offering recommendations on how to navigate a new era of…
-
Health and Wellness Brands Brace for Ad Restrictions on Meta
BranchLab CEO, Josh Walsh, weighs in on Meta’s move to implement stricter policies for health and wellness brands.
-
No More TV Drug Ads? Don’t Hold Your Breath
Does the incoming Trump administration and RFK Jr.’s potential appointment as the head of Health and Human Services (HHS) spell the end of TV drug ads? Probably not, argues Josh Walsh, CEO…
-
With RFK Headed to HHS, What Should Pharma Advertisers be Thinking About?
President-elect Donald Trump named Robert F. Kennedy Jr. as his pick to run the Department of Health and Human Services (HHS) when he returns to the White House. Kennedy has…
